Literature DB >> 9673750

Renal dysfunction and the treatment of inflammatory bowel disease (IBD): a case for monitoring.

G Howard, K L Lynn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9673750     DOI： 10.1111/j.1445-5994.1998.tb01962.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN： 0004-8291


× No keyword cloud information.
  3 in total

Review 1.  Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease.

Authors:  D Clemett; A Markham
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

2.  Interstitial nephritis from mesalazine: case report and literature review.

Authors:  Lois J Arend; James E Springate
Journal:  Pediatr Nephrol       Date:  2004-03-09       Impact factor: 3.714

Review 3.  5-ASA induced interstitial nephritis in patients with inflammatory bowel disease: a systematic review.

Authors:  James G Moss; Christopher M Parry; Richard C L Holt; Stephen J McWilliam
Journal:  Eur J Med Res       Date:  2022-04-29       Impact factor: 4.981
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.